Wedbush raises Burford Capital stock price target on book value

Wedbush raised its price target for Burford Capital (NYSE:BUR) to $3.25, citing tangible book value and valuation challenges. The stock trades at $3.65, above the target. Burford reported Q3 2026 capital provision income of $116M, EPS of $0.10, and reduced debt by $100M. Management remains optimistic despite interest-rate impacts.

Original reporting
Published Nov 12, 2026, 12:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BUR
Bearish
medium confidence
Mentioned
$BUR
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BURBearishMed
01

Why it matters

The lower price target relative to current trading levels may trigger short‑term selling pressure, but the improved balance sheet could support a longer‑term rebound.

02

Market read

Provides fresh earnings data and analyst guidance for a niche finance stock, offering a modest trading opportunity.

03

What to watch

Recent large cash settlement and debt reduction could improve cash flow outlook.

Relevance 6/10Novelty 7/10Timing: same-day today

Background

Burford Capital is a litigation‑finance company that recently posted strong Q3 earnings and a debt reduction, while Wedbush issued a new price target based on tangible book value.

Company-level read

Ticker impact

$BURBearishMedium confidence
Context

Wedbush raised its price target on Burford Capital to $3.25, below the current $3.65 price, and reported Q3 2026 earnings with book value growth and debt reduction.

Expected impact

likely pressure as investors price in the lower target and profitability concerns

Evidence & confidence

The new target is below market price and the company still shows negative ROE, indicating limited upside.

Market effects

Litigation finance sector may see heightened scrutiny on valuation multiples.

US small‑cap investors may adjust exposure to niche finance firms.

Limited to investors tracking niche finance stocks.

Counterpoint

The book‑value based target may undervalue future cash‑realization potential.

Key entities

  • Burford Capital

    Litigation‑finance firm (NYSE:BUR).

  • Wedbush

    Equity research firm that set the new price target.

Related articles

$BURMed

Burford Capital Q3 Earnings Call Highlights

Burford Capital reported a large U.S. patent verdict involving Apple, with uncertain valuation impact. The company reduced debt by $100M and lowered its debt-to-book ratio. Liquidity decreased to $514M, with $120M due from settlements. Management prioritized liquidity and deleveraging over new investments, with principal finance portfolio value rising to $2.5B. Expenses included $28M in case-related costs, with $10M in annual compensation savings.

MedAI 8/10

Burford Capital Limited Q3 2026 Earnings Call Summary

Burford Capital reported Q3 2026 revenue more than doubled year-over-year, with a 13.4% annualized ROE, though management noted it would have exceeded 40% without a 90-basis-point discount rate impact. The company reduced debt by $100 million and retired the 2028 maturity. A $64 million settlement yielded an 11x ROIC, and management expects the $2.5 billion portfolio to generate cash for years.